Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma 1

Interventions

Specimen Handling 217Magnetic Resonance Spectroscopy 194pembrolizumab 192Carboplatin 166Biopsy 134Cisplatin 129Nivolumab 126Paclitaxel 111Cyclophosphamide 110Radiotherapy 108Gemcitabine 97Dexamethasone 90durvalumab 88atezolizumab 75Radiation 71Lenalidomide 69Rituximab 68Doxorubicin 68Pemetrexed 62Bevacizumab 61Docetaxel 60Ipilimumab 59Etoposide 56Fluorouracil 52Radiosurgery 50Oxaliplatin 50olaparib 49Taxes 49Vincristine 46Prednisone 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × paricalcitol × 90 days × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡